nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—HTR2B—Raloxifene—osteoporosis	0.24	0.46	CbGbCtD
Lisuride—CYP3A4—Estropipate—osteoporosis	0.0446	0.0855	CbGbCtD
Lisuride—CYP3A4—Calcitriol—osteoporosis	0.0446	0.0855	CbGbCtD
Lisuride—CYP2D6—Cholecalciferol—osteoporosis	0.0361	0.0692	CbGbCtD
Lisuride—CYP3A4—Ergocalciferol—osteoporosis	0.0357	0.0683	CbGbCtD
Lisuride—CYP3A4—Raloxifene—osteoporosis	0.0298	0.057	CbGbCtD
Lisuride—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0287	0.0551	CbGbCtD
Lisuride—CYP3A4—Cholecalciferol—osteoporosis	0.023	0.044	CbGbCtD
Lisuride—CYP3A4—Conjugated Estrogens—osteoporosis	0.0211	0.0404	CbGbCtD
Lisuride—CYP3A4—Estradiol—osteoporosis	0.0185	0.0355	CbGbCtD
Lisuride—Weight increased—Ethinyl Estradiol—osteoporosis	0.00141	0.00439	CcSEcCtD
Lisuride—Weight decreased—Ethinyl Estradiol—osteoporosis	0.0014	0.00436	CcSEcCtD
Lisuride—Angiopathy—Estropipate—osteoporosis	0.00139	0.00432	CcSEcCtD
Lisuride—Immune system disorder—Estropipate—osteoporosis	0.00138	0.0043	CcSEcCtD
Lisuride—Mediastinal disorder—Estropipate—osteoporosis	0.00138	0.00429	CcSEcCtD
Lisuride—Cardiac disorder—Raloxifene—osteoporosis	0.00137	0.00428	CcSEcCtD
Lisuride—Asthenia—Calcium Acetate—osteoporosis	0.00137	0.00427	CcSEcCtD
Lisuride—Cardiac disorder—Ibandronate—osteoporosis	0.00136	0.00424	CcSEcCtD
Lisuride—Dehydration—Conjugated Estrogens—osteoporosis	0.00136	0.00423	CcSEcCtD
Lisuride—Angiopathy—Raloxifene—osteoporosis	0.00134	0.00418	CcSEcCtD
Lisuride—Mental disorder—Estropipate—osteoporosis	0.00134	0.00417	CcSEcCtD
Lisuride—Malnutrition—Estropipate—osteoporosis	0.00133	0.00414	CcSEcCtD
Lisuride—Angiopathy—Ibandronate—osteoporosis	0.00133	0.00414	CcSEcCtD
Lisuride—Immune system disorder—Ibandronate—osteoporosis	0.00132	0.00412	CcSEcCtD
Lisuride—Mediastinal disorder—Ibandronate—osteoporosis	0.00132	0.00411	CcSEcCtD
Lisuride—Mental disorder—Ibandronate—osteoporosis	0.00128	0.004	CcSEcCtD
Lisuride—Malnutrition—Ibandronate—osteoporosis	0.00128	0.00397	CcSEcCtD
Lisuride—Confusional state—Etidronic acid—osteoporosis	0.00127	0.00394	CcSEcCtD
Lisuride—Dizziness—Calcium Acetate—osteoporosis	0.00126	0.00394	CcSEcCtD
Lisuride—Abdominal discomfort—Zoledronate—osteoporosis	0.00126	0.00391	CcSEcCtD
Lisuride—Infection—Etidronic acid—osteoporosis	0.00125	0.00388	CcSEcCtD
Lisuride—Vomiting—Calcium Acetate—osteoporosis	0.00122	0.00379	CcSEcCtD
Lisuride—Asthenia—Ergocalciferol—osteoporosis	0.00121	0.00377	CcSEcCtD
Lisuride—Abdominal discomfort—Conjugated Estrogens—osteoporosis	0.00121	0.00377	CcSEcCtD
Lisuride—Vertigo—Estropipate—osteoporosis	0.0012	0.00372	CcSEcCtD
Lisuride—Weight increased—Zoledronate—osteoporosis	0.00119	0.00371	CcSEcCtD
Lisuride—Oedema peripheral—Risedronate—osteoporosis	0.00119	0.00371	CcSEcCtD
Lisuride—Weight decreased—Zoledronate—osteoporosis	0.00119	0.00369	CcSEcCtD
Lisuride—Vertigo—Alendronate—osteoporosis	0.00118	0.00367	CcSEcCtD
Lisuride—Palpitations—Estropipate—osteoporosis	0.00118	0.00366	CcSEcCtD
Lisuride—Cough—Estropipate—osteoporosis	0.00116	0.00362	CcSEcCtD
Lisuride—Disturbance in sexual arousal—Estradiol—osteoporosis	0.00116	0.00361	CcSEcCtD
Lisuride—Vertigo—Raloxifene—osteoporosis	0.00116	0.00361	CcSEcCtD
Lisuride—Syncope—Raloxifene—osteoporosis	0.00116	0.0036	CcSEcCtD
Lisuride—Weight increased—Conjugated Estrogens—osteoporosis	0.00115	0.00358	CcSEcCtD
Lisuride—Vertigo—Ibandronate—osteoporosis	0.00115	0.00357	CcSEcCtD
Lisuride—Anxiety—Estropipate—osteoporosis	0.00113	0.00352	CcSEcCtD
Lisuride—Palpitations—Ibandronate—osteoporosis	0.00113	0.00351	CcSEcCtD
Lisuride—Cough—Raloxifene—osteoporosis	0.00112	0.0035	CcSEcCtD
Lisuride—Angiopathy—Ethinyl Estradiol—osteoporosis	0.00112	0.0035	CcSEcCtD
Lisuride—Cardiac disorder—Risedronate—osteoporosis	0.00112	0.00349	CcSEcCtD
Lisuride—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.00112	0.00349	CcSEcCtD
Lisuride—Angiopathy—Risedronate—osteoporosis	0.0011	0.00341	CcSEcCtD
Lisuride—Immune system disorder—Risedronate—osteoporosis	0.00109	0.0034	CcSEcCtD
Lisuride—Mediastinal disorder—Risedronate—osteoporosis	0.00109	0.00339	CcSEcCtD
Lisuride—Mental disorder—Ethinyl Estradiol—osteoporosis	0.00109	0.00338	CcSEcCtD
Lisuride—Anxiety—Ibandronate—osteoporosis	0.00108	0.00337	CcSEcCtD
Lisuride—Infection—Estropipate—osteoporosis	0.00108	0.00336	CcSEcCtD
Lisuride—Malnutrition—Ethinyl Estradiol—osteoporosis	0.00108	0.00336	CcSEcCtD
Lisuride—Constipation—Etidronic acid—osteoporosis	0.00107	0.00334	CcSEcCtD
Lisuride—Cardiac disorder—Pamidronate—osteoporosis	0.00107	0.00332	CcSEcCtD
Lisuride—Nervous system disorder—Estropipate—osteoporosis	0.00106	0.00332	CcSEcCtD
Lisuride—Infection—Alendronate—osteoporosis	0.00106	0.00331	CcSEcCtD
Lisuride—Dry mouth—Ibandronate—osteoporosis	0.00106	0.00331	CcSEcCtD
Lisuride—Anxiety—Calcitriol—osteoporosis	0.00106	0.0033	CcSEcCtD
Lisuride—Mental disorder—Risedronate—osteoporosis	0.00106	0.0033	CcSEcCtD
Lisuride—Malnutrition—Risedronate—osteoporosis	0.00105	0.00328	CcSEcCtD
Lisuride—Infection—Raloxifene—osteoporosis	0.00104	0.00326	CcSEcCtD
Lisuride—Angiopathy—Pamidronate—osteoporosis	0.00104	0.00325	CcSEcCtD
Lisuride—Dry mouth—Calcitriol—osteoporosis	0.00104	0.00324	CcSEcCtD
Lisuride—Immune system disorder—Pamidronate—osteoporosis	0.00104	0.00323	CcSEcCtD
Lisuride—Mediastinal disorder—Pamidronate—osteoporosis	0.00103	0.00322	CcSEcCtD
Lisuride—Infection—Ibandronate—osteoporosis	0.00103	0.00322	CcSEcCtD
Lisuride—Feeling abnormal—Etidronic acid—osteoporosis	0.00103	0.00322	CcSEcCtD
Lisuride—Oedema peripheral—Zoledronate—osteoporosis	0.00103	0.00322	CcSEcCtD
Lisuride—Nervous system disorder—Raloxifene—osteoporosis	0.00103	0.00321	CcSEcCtD
Lisuride—Nervous system disorder—Ibandronate—osteoporosis	0.00102	0.00318	CcSEcCtD
Lisuride—Hyperhidrosis—Raloxifene—osteoporosis	0.00102	0.00317	CcSEcCtD
Lisuride—Hyperhidrosis—Ibandronate—osteoporosis	0.00101	0.00314	CcSEcCtD
Lisuride—Malnutrition—Pamidronate—osteoporosis	0.001	0.00311	CcSEcCtD
Lisuride—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.000995	0.0031	CcSEcCtD
Lisuride—Insomnia—Estropipate—osteoporosis	0.000982	0.00306	CcSEcCtD
Lisuride—Cardiac disorder—Zoledronate—osteoporosis	0.000973	0.00303	CcSEcCtD
Lisuride—Anorexia—Calcitriol—osteoporosis	0.000972	0.00303	CcSEcCtD
Lisuride—Abdominal discomfort—Estradiol—osteoporosis	0.000968	0.00302	CcSEcCtD
Lisuride—Somnolence—Estropipate—osteoporosis	0.000965	0.00301	CcSEcCtD
Lisuride—Angiopathy—Zoledronate—osteoporosis	0.000952	0.00296	CcSEcCtD
Lisuride—Insomnia—Raloxifene—osteoporosis	0.000951	0.00296	CcSEcCtD
Lisuride—Immune system disorder—Zoledronate—osteoporosis	0.000947	0.00295	CcSEcCtD
Lisuride—Mediastinal disorder—Zoledronate—osteoporosis	0.000945	0.00294	CcSEcCtD
Lisuride—Vertigo—Risedronate—osteoporosis	0.000945	0.00294	CcSEcCtD
Lisuride—Syncope—Risedronate—osteoporosis	0.000943	0.00294	CcSEcCtD
Lisuride—Insomnia—Ibandronate—osteoporosis	0.000942	0.00293	CcSEcCtD
Lisuride—Cough—Ethinyl Estradiol—osteoporosis	0.000941	0.00293	CcSEcCtD
Lisuride—Gastrointestinal disorder—Estropipate—osteoporosis	0.000937	0.00292	CcSEcCtD
Lisuride—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000937	0.00292	CcSEcCtD
Lisuride—Fatigue—Estropipate—osteoporosis	0.000936	0.00292	CcSEcCtD
Lisuride—Constipation—Estropipate—osteoporosis	0.000929	0.00289	CcSEcCtD
Lisuride—Insomnia—Calcitriol—osteoporosis	0.000922	0.00287	CcSEcCtD
Lisuride—Weight increased—Estradiol—osteoporosis	0.000919	0.00286	CcSEcCtD
Lisuride—Mental disorder—Zoledronate—osteoporosis	0.000919	0.00286	CcSEcCtD
Lisuride—Cough—Risedronate—osteoporosis	0.000918	0.00286	CcSEcCtD
Lisuride—Angiopathy—Conjugated Estrogens—osteoporosis	0.000916	0.00285	CcSEcCtD
Lisuride—Anxiety—Ethinyl Estradiol—osteoporosis	0.000915	0.00285	CcSEcCtD
Lisuride—Constipation—Alendronate—osteoporosis	0.000915	0.00285	CcSEcCtD
Lisuride—Weight decreased—Estradiol—osteoporosis	0.000914	0.00285	CcSEcCtD
Lisuride—Malnutrition—Zoledronate—osteoporosis	0.000913	0.00284	CcSEcCtD
Lisuride—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000912	0.00284	CcSEcCtD
Lisuride—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.00091	0.00284	CcSEcCtD
Lisuride—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000908	0.00283	CcSEcCtD
Lisuride—Somnolence—Calcitriol—osteoporosis	0.000906	0.00282	CcSEcCtD
Lisuride—Decreased appetite—Ibandronate—osteoporosis	0.000905	0.00282	CcSEcCtD
Lisuride—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000899	0.0028	CcSEcCtD
Lisuride—Fatigue—Ibandronate—osteoporosis	0.000898	0.0028	CcSEcCtD
Lisuride—Syncope—Pamidronate—osteoporosis	0.000896	0.00279	CcSEcCtD
Lisuride—Anxiety—Risedronate—osteoporosis	0.000892	0.00278	CcSEcCtD
Lisuride—Constipation—Ibandronate—osteoporosis	0.00089	0.00277	CcSEcCtD
Lisuride—Decreased appetite—Calcitriol—osteoporosis	0.000886	0.00276	CcSEcCtD
Lisuride—Mental disorder—Conjugated Estrogens—osteoporosis	0.000885	0.00276	CcSEcCtD
Lisuride—Feeling abnormal—Alendronate—osteoporosis	0.000881	0.00275	CcSEcCtD
Lisuride—Malnutrition—Conjugated Estrogens—osteoporosis	0.000879	0.00274	CcSEcCtD
Lisuride—Dry mouth—Risedronate—osteoporosis	0.000876	0.00273	CcSEcCtD
Lisuride—Infection—Ethinyl Estradiol—osteoporosis	0.000874	0.00272	CcSEcCtD
Lisuride—Cough—Pamidronate—osteoporosis	0.000872	0.00272	CcSEcCtD
Lisuride—Constipation—Calcitriol—osteoporosis	0.000872	0.00272	CcSEcCtD
Lisuride—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000863	0.00269	CcSEcCtD
Lisuride—Feeling abnormal—Ibandronate—osteoporosis	0.000858	0.00267	CcSEcCtD
Lisuride—Infection—Risedronate—osteoporosis	0.000853	0.00266	CcSEcCtD
Lisuride—Anxiety—Pamidronate—osteoporosis	0.000848	0.00264	CcSEcCtD
Lisuride—Nervous system disorder—Risedronate—osteoporosis	0.000842	0.00262	CcSEcCtD
Lisuride—Confusional state—Pamidronate—osteoporosis	0.000823	0.00256	CcSEcCtD
Lisuride—Vertigo—Zoledronate—osteoporosis	0.00082	0.00256	CcSEcCtD
Lisuride—Syncope—Zoledronate—osteoporosis	0.000819	0.00255	CcSEcCtD
Lisuride—Infection—Pamidronate—osteoporosis	0.00081	0.00252	CcSEcCtD
Lisuride—Palpitations—Zoledronate—osteoporosis	0.000807	0.00251	CcSEcCtD
Lisuride—Nervous system disorder—Pamidronate—osteoporosis	0.0008	0.00249	CcSEcCtD
Lisuride—Vomiting—Etidronic acid—osteoporosis	0.000798	0.00249	CcSEcCtD
Lisuride—Cough—Zoledronate—osteoporosis	0.000797	0.00248	CcSEcCtD
Lisuride—Oedema peripheral—Estradiol—osteoporosis	0.000796	0.00248	CcSEcCtD
Lisuride—Tachycardia—Pamidronate—osteoporosis	0.000796	0.00248	CcSEcCtD
Lisuride—Vertigo—Conjugated Estrogens—osteoporosis	0.00079	0.00246	CcSEcCtD
Lisuride—Hyperhidrosis—Pamidronate—osteoporosis	0.000789	0.00246	CcSEcCtD
Lisuride—Syncope—Conjugated Estrogens—osteoporosis	0.000788	0.00246	CcSEcCtD
Lisuride—Headache—Etidronic acid—osteoporosis	0.000786	0.00245	CcSEcCtD
Lisuride—Asthenia—Estropipate—osteoporosis	0.000779	0.00243	CcSEcCtD
Lisuride—Anorexia—Pamidronate—osteoporosis	0.000778	0.00242	CcSEcCtD
Lisuride—Palpitations—Conjugated Estrogens—osteoporosis	0.000777	0.00242	CcSEcCtD
Lisuride—Insomnia—Risedronate—osteoporosis	0.000776	0.00242	CcSEcCtD
Lisuride—Anxiety—Zoledronate—osteoporosis	0.000775	0.00241	CcSEcCtD
Lisuride—Asthenia—Alendronate—osteoporosis	0.000767	0.00239	CcSEcCtD
Lisuride—Cough—Conjugated Estrogens—osteoporosis	0.000767	0.00239	CcSEcCtD
Lisuride—Dyspnoea—Risedronate—osteoporosis	0.000765	0.00238	CcSEcCtD
Lisuride—Dry mouth—Zoledronate—osteoporosis	0.00076	0.00237	CcSEcCtD
Lisuride—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00076	0.00237	CcSEcCtD
Lisuride—Fatigue—Ethinyl Estradiol—osteoporosis	0.000759	0.00236	CcSEcCtD
Lisuride—Constipation—Ethinyl Estradiol—osteoporosis	0.000753	0.00234	CcSEcCtD
Lisuride—Confusional state—Zoledronate—osteoporosis	0.000751	0.00234	CcSEcCtD
Lisuride—Cardiac disorder—Estradiol—osteoporosis	0.00075	0.00234	CcSEcCtD
Lisuride—Asthenia—Ibandronate—osteoporosis	0.000747	0.00233	CcSEcCtD
Lisuride—Anxiety—Conjugated Estrogens—osteoporosis	0.000746	0.00232	CcSEcCtD
Lisuride—Gastrointestinal disorder—Risedronate—osteoporosis	0.000741	0.00231	CcSEcCtD
Lisuride—Infection—Zoledronate—osteoporosis	0.00074	0.00231	CcSEcCtD
Lisuride—Fatigue—Risedronate—osteoporosis	0.00074	0.0023	CcSEcCtD
Lisuride—Insomnia—Pamidronate—osteoporosis	0.000738	0.0023	CcSEcCtD
Lisuride—Constipation—Risedronate—osteoporosis	0.000734	0.00229	CcSEcCtD
Lisuride—Angiopathy—Estradiol—osteoporosis	0.000733	0.00228	CcSEcCtD
Lisuride—Asthenia—Calcitriol—osteoporosis	0.000731	0.00228	CcSEcCtD
Lisuride—Nervous system disorder—Zoledronate—osteoporosis	0.000731	0.00228	CcSEcCtD
Lisuride—Immune system disorder—Estradiol—osteoporosis	0.00073	0.00227	CcSEcCtD
Lisuride—Mediastinal disorder—Estradiol—osteoporosis	0.000728	0.00227	CcSEcCtD
Lisuride—Dyspnoea—Pamidronate—osteoporosis	0.000727	0.00227	CcSEcCtD
Lisuride—Tachycardia—Zoledronate—osteoporosis	0.000727	0.00227	CcSEcCtD
Lisuride—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000725	0.00226	CcSEcCtD
Lisuride—Somnolence—Pamidronate—osteoporosis	0.000725	0.00226	CcSEcCtD
Lisuride—Hyperhidrosis—Zoledronate—osteoporosis	0.00072	0.00224	CcSEcCtD
Lisuride—Dizziness—Estropipate—osteoporosis	0.000718	0.00224	CcSEcCtD
Lisuride—Infection—Conjugated Estrogens—osteoporosis	0.000713	0.00222	CcSEcCtD
Lisuride—Anorexia—Zoledronate—osteoporosis	0.00071	0.00221	CcSEcCtD
Lisuride—Decreased appetite—Pamidronate—osteoporosis	0.000709	0.00221	CcSEcCtD
Lisuride—Mental disorder—Estradiol—osteoporosis	0.000708	0.00221	CcSEcCtD
Lisuride—Dizziness—Alendronate—osteoporosis	0.000707	0.0022	CcSEcCtD
Lisuride—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000704	0.00219	CcSEcCtD
Lisuride—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000704	0.00219	CcSEcCtD
Lisuride—Malnutrition—Estradiol—osteoporosis	0.000704	0.00219	CcSEcCtD
Lisuride—Fatigue—Pamidronate—osteoporosis	0.000703	0.00219	CcSEcCtD
Lisuride—Tachycardia—Conjugated Estrogens—osteoporosis	0.0007	0.00218	CcSEcCtD
Lisuride—Constipation—Pamidronate—osteoporosis	0.000698	0.00217	CcSEcCtD
Lisuride—Dizziness—Raloxifene—osteoporosis	0.000696	0.00217	CcSEcCtD
Lisuride—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000694	0.00216	CcSEcCtD
Lisuride—Vomiting—Estropipate—osteoporosis	0.00069	0.00215	CcSEcCtD
Lisuride—Dizziness—Ibandronate—osteoporosis	0.000689	0.00215	CcSEcCtD
Lisuride—Anorexia—Conjugated Estrogens—osteoporosis	0.000684	0.00213	CcSEcCtD
Lisuride—Headache—Estropipate—osteoporosis	0.00068	0.00212	CcSEcCtD
Lisuride—Vomiting—Alendronate—osteoporosis	0.00068	0.00212	CcSEcCtD
Lisuride—Insomnia—Zoledronate—osteoporosis	0.000674	0.0021	CcSEcCtD
Lisuride—Feeling abnormal—Pamidronate—osteoporosis	0.000672	0.00209	CcSEcCtD
Lisuride—Headache—Alendronate—osteoporosis	0.00067	0.00209	CcSEcCtD
Lisuride—Vomiting—Raloxifene—osteoporosis	0.000669	0.00208	CcSEcCtD
Lisuride—Dyspnoea—Zoledronate—osteoporosis	0.000664	0.00207	CcSEcCtD
Lisuride—Somnolence—Zoledronate—osteoporosis	0.000662	0.00206	CcSEcCtD
Lisuride—Vomiting—Ibandronate—osteoporosis	0.000662	0.00206	CcSEcCtD
Lisuride—Headache—Raloxifene—osteoporosis	0.000659	0.00205	CcSEcCtD
Lisuride—Headache—Ibandronate—osteoporosis	0.000652	0.00203	CcSEcCtD
Lisuride—Insomnia—Conjugated Estrogens—osteoporosis	0.000649	0.00202	CcSEcCtD
Lisuride—Vomiting—Calcitriol—osteoporosis	0.000648	0.00202	CcSEcCtD
Lisuride—Decreased appetite—Zoledronate—osteoporosis	0.000648	0.00202	CcSEcCtD
Lisuride—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000643	0.002	CcSEcCtD
Lisuride—Fatigue—Zoledronate—osteoporosis	0.000642	0.002	CcSEcCtD
Lisuride—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00064	0.00199	CcSEcCtD
Lisuride—Headache—Calcitriol—osteoporosis	0.000639	0.00199	CcSEcCtD
Lisuride—Somnolence—Conjugated Estrogens—osteoporosis	0.000638	0.00199	CcSEcCtD
Lisuride—Constipation—Zoledronate—osteoporosis	0.000637	0.00199	CcSEcCtD
Lisuride—Vertigo—Estradiol—osteoporosis	0.000632	0.00197	CcSEcCtD
Lisuride—Asthenia—Ethinyl Estradiol—osteoporosis	0.000632	0.00197	CcSEcCtD
Lisuride—Syncope—Estradiol—osteoporosis	0.000631	0.00197	CcSEcCtD
Lisuride—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000624	0.00194	CcSEcCtD
Lisuride—Palpitations—Estradiol—osteoporosis	0.000622	0.00194	CcSEcCtD
Lisuride—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000619	0.00193	CcSEcCtD
Lisuride—Fatigue—Conjugated Estrogens—osteoporosis	0.000619	0.00193	CcSEcCtD
Lisuride—Asthenia—Risedronate—osteoporosis	0.000616	0.00192	CcSEcCtD
Lisuride—Feeling abnormal—Zoledronate—osteoporosis	0.000614	0.00191	CcSEcCtD
Lisuride—Cough—Estradiol—osteoporosis	0.000614	0.00191	CcSEcCtD
Lisuride—Constipation—Conjugated Estrogens—osteoporosis	0.000614	0.00191	CcSEcCtD
Lisuride—Anxiety—Estradiol—osteoporosis	0.000597	0.00186	CcSEcCtD
Lisuride—Dry mouth—Estradiol—osteoporosis	0.000586	0.00183	CcSEcCtD
Lisuride—Asthenia—Pamidronate—osteoporosis	0.000585	0.00182	CcSEcCtD
Lisuride—Dizziness—Ethinyl Estradiol—osteoporosis	0.000582	0.00181	CcSEcCtD
Lisuride—Confusional state—Estradiol—osteoporosis	0.000579	0.0018	CcSEcCtD
Lisuride—Infection—Estradiol—osteoporosis	0.000571	0.00178	CcSEcCtD
Lisuride—Dizziness—Risedronate—osteoporosis	0.000567	0.00177	CcSEcCtD
Lisuride—Nervous system disorder—Estradiol—osteoporosis	0.000563	0.00175	CcSEcCtD
Lisuride—Tachycardia—Estradiol—osteoporosis	0.00056	0.00175	CcSEcCtD
Lisuride—Vomiting—Ethinyl Estradiol—osteoporosis	0.00056	0.00174	CcSEcCtD
Lisuride—Hyperhidrosis—Estradiol—osteoporosis	0.000555	0.00173	CcSEcCtD
Lisuride—Headache—Ethinyl Estradiol—osteoporosis	0.000551	0.00172	CcSEcCtD
Lisuride—Vomiting—Risedronate—osteoporosis	0.000546	0.0017	CcSEcCtD
Lisuride—Dizziness—Pamidronate—osteoporosis	0.000539	0.00168	CcSEcCtD
Lisuride—Headache—Risedronate—osteoporosis	0.000538	0.00167	CcSEcCtD
Lisuride—Asthenia—Zoledronate—osteoporosis	0.000535	0.00167	CcSEcCtD
Lisuride—Insomnia—Estradiol—osteoporosis	0.000519	0.00162	CcSEcCtD
Lisuride—Vomiting—Pamidronate—osteoporosis	0.000519	0.00162	CcSEcCtD
Lisuride—Asthenia—Conjugated Estrogens—osteoporosis	0.000515	0.0016	CcSEcCtD
Lisuride—Dyspnoea—Estradiol—osteoporosis	0.000512	0.00159	CcSEcCtD
Lisuride—Headache—Pamidronate—osteoporosis	0.000511	0.00159	CcSEcCtD
Lisuride—Somnolence—Estradiol—osteoporosis	0.000511	0.00159	CcSEcCtD
Lisuride—Decreased appetite—Estradiol—osteoporosis	0.000499	0.00156	CcSEcCtD
Lisuride—Gastrointestinal disorder—Estradiol—osteoporosis	0.000496	0.00154	CcSEcCtD
Lisuride—Fatigue—Estradiol—osteoporosis	0.000495	0.00154	CcSEcCtD
Lisuride—Dizziness—Zoledronate—osteoporosis	0.000493	0.00154	CcSEcCtD
Lisuride—Constipation—Estradiol—osteoporosis	0.000491	0.00153	CcSEcCtD
Lisuride—Dizziness—Conjugated Estrogens—osteoporosis	0.000474	0.00148	CcSEcCtD
Lisuride—Vomiting—Zoledronate—osteoporosis	0.000474	0.00148	CcSEcCtD
Lisuride—Feeling abnormal—Estradiol—osteoporosis	0.000473	0.00147	CcSEcCtD
Lisuride—Headache—Zoledronate—osteoporosis	0.000467	0.00145	CcSEcCtD
Lisuride—Vomiting—Conjugated Estrogens—osteoporosis	0.000456	0.00142	CcSEcCtD
Lisuride—Headache—Conjugated Estrogens—osteoporosis	0.00045	0.0014	CcSEcCtD
Lisuride—Asthenia—Estradiol—osteoporosis	0.000412	0.00128	CcSEcCtD
Lisuride—Dizziness—Estradiol—osteoporosis	0.00038	0.00118	CcSEcCtD
Lisuride—Vomiting—Estradiol—osteoporosis	0.000365	0.00114	CcSEcCtD
Lisuride—Headache—Estradiol—osteoporosis	0.00036	0.00112	CcSEcCtD
Lisuride—CYP3A4—Metabolism—MGLL—osteoporosis	2.61e-05	0.000166	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—ADCY5—osteoporosis	2.61e-05	0.000166	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—RAP1A—osteoporosis	2.6e-05	0.000165	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—ADCY5—osteoporosis	2.59e-05	0.000165	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	2.59e-05	0.000165	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—GPX1—osteoporosis	2.58e-05	0.000164	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—CYP19A1—osteoporosis	2.58e-05	0.000164	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IRS2—osteoporosis	2.57e-05	0.000164	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—LEP—osteoporosis	2.57e-05	0.000164	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—ADCY5—osteoporosis	2.57e-05	0.000164	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—ADCY5—osteoporosis	2.57e-05	0.000164	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IRS2—osteoporosis	2.53e-05	0.000161	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—SPP1—osteoporosis	2.52e-05	0.00016	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—LEP—osteoporosis	2.52e-05	0.00016	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—KL—osteoporosis	2.51e-05	0.00016	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—SPP1—osteoporosis	2.49e-05	0.000158	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—SPP1—osteoporosis	2.49e-05	0.000158	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—LEP—osteoporosis	2.48e-05	0.000158	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CALCA—osteoporosis	2.48e-05	0.000158	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—KL—osteoporosis	2.47e-05	0.000157	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—ESR1—osteoporosis	2.46e-05	0.000156	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—POMC—osteoporosis	2.45e-05	0.000156	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IRS2—osteoporosis	2.42e-05	0.000154	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	2.41e-05	0.000154	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—POMC—osteoporosis	2.41e-05	0.000153	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—ESR1—osteoporosis	2.4e-05	0.000153	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—IL6R—osteoporosis	2.39e-05	0.000152	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—MTHFR—osteoporosis	2.38e-05	0.000152	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—ESR1—osteoporosis	2.37e-05	0.000151	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—LEP—osteoporosis	2.37e-05	0.000151	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—IL6R—osteoporosis	2.35e-05	0.00015	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—ADCY5—osteoporosis	2.34e-05	0.000149	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	2.32e-05	0.000148	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IRS1—osteoporosis	2.29e-05	0.000146	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IRS2—osteoporosis	2.28e-05	0.000145	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—SPP1—osteoporosis	2.27e-05	0.000144	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—ESR1—osteoporosis	2.26e-05	0.000144	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IRS2—osteoporosis	2.25e-05	0.000143	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IRS2—osteoporosis	2.25e-05	0.000143	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—KL—osteoporosis	2.25e-05	0.000143	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IRS1—osteoporosis	2.25e-05	0.000143	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—SPP1—osteoporosis	2.25e-05	0.000143	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—ADCY5—osteoporosis	2.24e-05	0.000143	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—LEP—osteoporosis	2.23e-05	0.000142	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—ADCY5—osteoporosis	2.23e-05	0.000142	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—IDH2—osteoporosis	2.22e-05	0.000142	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IRS1—osteoporosis	2.21e-05	0.000141	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—POMC—osteoporosis	2.21e-05	0.000141	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—TGFB1—osteoporosis	2.2e-05	0.00014	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—LEP—osteoporosis	2.2e-05	0.00014	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—LEP—osteoporosis	2.2e-05	0.00014	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—POMC—osteoporosis	2.19e-05	0.00014	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	2.17e-05	0.000138	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—SPP1—osteoporosis	2.17e-05	0.000138	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—POMC—osteoporosis	2.16e-05	0.000138	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—SPP1—osteoporosis	2.16e-05	0.000137	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL6R—osteoporosis	2.16e-05	0.000137	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	2.14e-05	0.000136	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	2.13e-05	0.000136	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—ESR1—osteoporosis	2.13e-05	0.000136	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—POMC—osteoporosis	2.13e-05	0.000135	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IGF1—osteoporosis	2.13e-05	0.000135	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—IL6—osteoporosis	2.12e-05	0.000135	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IRS1—osteoporosis	2.11e-05	0.000134	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL6R—osteoporosis	2.11e-05	0.000134	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—ADCY5—osteoporosis	2.11e-05	0.000134	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—ESR1—osteoporosis	2.1e-05	0.000134	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—ESR1—osteoporosis	2.1e-05	0.000134	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—ENO1—osteoporosis	2.1e-05	0.000134	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—GPX1—osteoporosis	2.1e-05	0.000134	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—SPP1—osteoporosis	2.1e-05	0.000133	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.09e-05	0.000133	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IGF1—osteoporosis	2.08e-05	0.000132	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL6R—osteoporosis	2.08e-05	0.000132	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PSMA2—osteoporosis	2.07e-05	0.000132	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PSMA5—osteoporosis	2.07e-05	0.000132	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—SPP1—osteoporosis	2.06e-05	0.000131	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IRS2—osteoporosis	2.05e-05	0.00013	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IGF1—osteoporosis	2.05e-05	0.00013	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ACP5—osteoporosis	2.03e-05	0.000129	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—POMC—osteoporosis	2.03e-05	0.000129	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IRS2—osteoporosis	2.03e-05	0.000129	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—LEP—osteoporosis	2.01e-05	0.000128	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IRS1—osteoporosis	1.99e-05	0.000127	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—LEP—osteoporosis	1.99e-05	0.000126	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL6R—osteoporosis	1.98e-05	0.000126	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.97e-05	0.000125	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IRS1—osteoporosis	1.96e-05	0.000125	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IRS1—osteoporosis	1.96e-05	0.000125	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.96e-05	0.000125	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IGF1—osteoporosis	1.95e-05	0.000124	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.95e-05	0.000124	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—MTHFR—osteoporosis	1.94e-05	0.000123	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.94e-05	0.000123	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—LEP—osteoporosis	1.92e-05	0.000122	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—POMC—osteoporosis	1.92e-05	0.000122	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—ESR1—osteoporosis	1.91e-05	0.000122	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—LEP—osteoporosis	1.91e-05	0.000121	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—POMC—osteoporosis	1.91e-05	0.000121	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—SPP1—osteoporosis	1.9e-05	0.000121	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—ESR1—osteoporosis	1.9e-05	0.000121	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IRS2—osteoporosis	1.9e-05	0.000121	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—POMC—osteoporosis	1.89e-05	0.00012	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—POMC—osteoporosis	1.89e-05	0.00012	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—TPI1—osteoporosis	1.89e-05	0.00012	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.87e-05	0.000119	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL6R—osteoporosis	1.87e-05	0.000119	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IRS2—osteoporosis	1.87e-05	0.000119	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—LEP—osteoporosis	1.86e-05	0.000118	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL6R—osteoporosis	1.84e-05	0.000117	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL6R—osteoporosis	1.84e-05	0.000117	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IGF1—osteoporosis	1.84e-05	0.000117	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.83e-05	0.000117	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—LEP—osteoporosis	1.83e-05	0.000116	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.82e-05	0.000116	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IGF1—osteoporosis	1.82e-05	0.000116	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IGF1—osteoporosis	1.82e-05	0.000116	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IRS1—osteoporosis	1.79e-05	0.000114	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—P4HB—osteoporosis	1.78e-05	0.000113	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IRS1—osteoporosis	1.77e-05	0.000113	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—ESR1—osteoporosis	1.77e-05	0.000113	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.76e-05	0.000112	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GAPDH—osteoporosis	1.74e-05	0.000111	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—ESR1—osteoporosis	1.74e-05	0.000111	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—POMC—osteoporosis	1.72e-05	0.00011	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IRS2—osteoporosis	1.72e-05	0.00011	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.71e-05	0.000109	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—POMC—osteoporosis	1.71e-05	0.000109	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.7e-05	0.000108	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.7e-05	0.000108	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—RAP1A—osteoporosis	1.7e-05	0.000108	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.69e-05	0.000108	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—LEP—osteoporosis	1.68e-05	0.000107	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL6R—osteoporosis	1.68e-05	0.000107	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.68e-05	0.000107	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—MYC—osteoporosis	1.67e-05	0.000106	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL6R—osteoporosis	1.67e-05	0.000106	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—TGFB1—osteoporosis	1.66e-05	0.000106	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—LEP—osteoporosis	1.66e-05	0.000105	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IGF1—osteoporosis	1.66e-05	0.000105	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IRS1—osteoporosis	1.66e-05	0.000105	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—POMC—osteoporosis	1.65e-05	0.000105	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IGF1—osteoporosis	1.64e-05	0.000105	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—POMC—osteoporosis	1.64e-05	0.000104	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IRS1—osteoporosis	1.63e-05	0.000104	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—IL6—osteoporosis	1.63e-05	0.000103	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—ESR1—osteoporosis	1.61e-05	0.000102	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL6R—osteoporosis	1.61e-05	0.000102	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL6R—osteoporosis	1.6e-05	0.000102	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—POMC—osteoporosis	1.59e-05	0.000101	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—IL6—osteoporosis	1.59e-05	0.000101	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IGF1—osteoporosis	1.59e-05	0.000101	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—ESR1—osteoporosis	1.58e-05	0.000101	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IGF1—osteoporosis	1.58e-05	0.0001	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—POMC—osteoporosis	1.57e-05	9.99e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—IL6—osteoporosis	1.57e-05	9.97e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL6R—osteoporosis	1.56e-05	9.9e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—POMC—osteoporosis	1.55e-05	9.86e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IRS2—osteoporosis	1.54e-05	9.81e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IGF1—osteoporosis	1.53e-05	9.76e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL6R—osteoporosis	1.53e-05	9.74e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IGF1—osteoporosis	1.51e-05	9.61e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—LEP—osteoporosis	1.51e-05	9.6e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IRS1—osteoporosis	1.5e-05	9.56e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—IL6—osteoporosis	1.49e-05	9.51e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IRS1—osteoporosis	1.48e-05	9.41e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—POMC—osteoporosis	1.45e-05	9.21e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—ESR1—osteoporosis	1.44e-05	9.16e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—POMC—osteoporosis	1.42e-05	9.06e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL6R—osteoporosis	1.41e-05	8.98e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—IL6—osteoporosis	1.41e-05	8.97e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IGF1—osteoporosis	1.39e-05	8.86e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—IL6—osteoporosis	1.39e-05	8.85e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—IL6—osteoporosis	1.39e-05	8.85e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL6R—osteoporosis	1.39e-05	8.84e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ENO1—osteoporosis	1.37e-05	8.74e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—ADCY5—osteoporosis	1.37e-05	8.73e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IGF1—osteoporosis	1.37e-05	8.72e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GPX1—osteoporosis	1.37e-05	8.7e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PSMA2—osteoporosis	1.35e-05	8.61e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PSMA5—osteoporosis	1.35e-05	8.61e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IRS1—osteoporosis	1.35e-05	8.56e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—POMC—osteoporosis	1.3e-05	8.24e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—MYC—osteoporosis	1.28e-05	8.13e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TGFB1—osteoporosis	1.27e-05	8.11e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—IL6—osteoporosis	1.27e-05	8.07e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL6R—osteoporosis	1.26e-05	8.04e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—MTHFR—osteoporosis	1.26e-05	8.03e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—IL6—osteoporosis	1.26e-05	7.99e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—IL6—osteoporosis	1.25e-05	7.98e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—MYC—osteoporosis	1.25e-05	7.96e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TGFB1—osteoporosis	1.25e-05	7.94e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IGF1—osteoporosis	1.25e-05	7.93e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—MYC—osteoporosis	1.23e-05	7.83e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TGFB1—osteoporosis	1.23e-05	7.81e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—IL6—osteoporosis	1.21e-05	7.72e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—IL6—osteoporosis	1.21e-05	7.68e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—MYC—osteoporosis	1.17e-05	7.48e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—IL6—osteoporosis	1.17e-05	7.47e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TGFB1—osteoporosis	1.17e-05	7.46e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—IL6—osteoporosis	1.15e-05	7.35e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—MYC—osteoporosis	1.11e-05	7.05e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TGFB1—osteoporosis	1.11e-05	7.03e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.1e-05	6.99e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—MYC—osteoporosis	1.09e-05	6.96e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—MYC—osteoporosis	1.09e-05	6.96e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	1.09e-05	6.94e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TGFB1—osteoporosis	1.09e-05	6.94e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—IL6—osteoporosis	1.06e-05	6.77e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—IL6—osteoporosis	1.05e-05	6.67e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—POMC—osteoporosis	1.01e-05	6.42e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—MYC—osteoporosis	9.96e-06	6.34e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TGFB1—osteoporosis	9.94e-06	6.32e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—MYC—osteoporosis	9.87e-06	6.28e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	9.84e-06	6.27e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL6—osteoporosis	9.6e-06	6.11e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL6—osteoporosis	9.53e-06	6.06e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—MYC—osteoporosis	9.53e-06	6.06e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TGFB1—osteoporosis	9.5e-06	6.05e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—MYC—osteoporosis	9.48e-06	6.03e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TGFB1—osteoporosis	9.45e-06	6.02e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL6—osteoporosis	9.4e-06	5.98e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL6—osteoporosis	9.25e-06	5.89e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—MYC—osteoporosis	9.22e-06	5.87e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	9.2e-06	5.85e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—MYC—osteoporosis	9.07e-06	5.77e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	9.05e-06	5.76e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ADCY5—osteoporosis	8.97e-06	5.71e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GPX1—osteoporosis	8.94e-06	5.69e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL6—osteoporosis	8.83e-06	5.62e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MYC—osteoporosis	8.36e-06	5.32e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TGFB1—osteoporosis	8.34e-06	5.31e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL6—osteoporosis	8.33e-06	5.3e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—MTHFR—osteoporosis	8.25e-06	5.25e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MYC—osteoporosis	8.23e-06	5.24e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL6—osteoporosis	8.22e-06	5.23e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL6—osteoporosis	8.22e-06	5.23e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TGFB1—osteoporosis	8.21e-06	5.23e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MYC—osteoporosis	7.49e-06	4.77e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL6—osteoporosis	7.49e-06	4.76e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	7.47e-06	4.75e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL6—osteoporosis	7.42e-06	4.72e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL6—osteoporosis	7.16e-06	4.56e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL6—osteoporosis	7.12e-06	4.53e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL6—osteoporosis	6.93e-06	4.41e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL6—osteoporosis	6.82e-06	4.34e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—POMC—osteoporosis	6.6e-06	4.2e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL6—osteoporosis	6.29e-06	4e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL6—osteoporosis	6.19e-06	3.94e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL6—osteoporosis	5.63e-06	3.58e-05	CbGpPWpGaD
